Kovack Advisors Inc. Buys 340 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Kovack Advisors Inc. raised its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 4.2% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 8,481 shares of the biotechnology company’s stock after purchasing an additional 340 shares during the period. Kovack Advisors Inc.’s holdings in Axon Enterprise were worth $3,389,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Envestnet Portfolio Solutions Inc. lifted its position in Axon Enterprise by 11.8% in the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 4,468 shares of the biotechnology company’s stock worth $1,398,000 after buying an additional 471 shares during the last quarter. Empowered Funds LLC bought a new stake in shares of Axon Enterprise in the 1st quarter worth approximately $340,000. Concurrent Investment Advisors LLC purchased a new stake in shares of Axon Enterprise in the 1st quarter valued at $216,000. Russell Investments Group Ltd. grew its holdings in shares of Axon Enterprise by 18.9% during the 1st quarter. Russell Investments Group Ltd. now owns 62,466 shares of the biotechnology company’s stock valued at $19,572,000 after purchasing an additional 9,925 shares during the last quarter. Finally, Avantax Advisory Services Inc. raised its position in Axon Enterprise by 0.8% in the 1st quarter. Avantax Advisory Services Inc. now owns 5,302 shares of the biotechnology company’s stock worth $1,659,000 after purchasing an additional 40 shares during the period. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Axon Enterprise Stock Up 3.5 %

Shares of AXON stock traded up $20.64 during midday trading on Wednesday, reaching $615.82. 148,475 shares of the stock were exchanged, compared to its average volume of 546,276. Axon Enterprise, Inc. has a 1 year low of $220.51 and a 1 year high of $624.84. The firm has a market cap of $46.96 billion, a PE ratio of 153.79, a price-to-earnings-growth ratio of 15.47 and a beta of 0.94. The company’s 50 day moving average is $423.98 and its two-hundred day moving average is $351.79. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on AXON. Robert W. Baird raised their price objective on Axon Enterprise from $440.00 to $460.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. Northland Securities raised their price target on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday. The Goldman Sachs Group boosted their price objective on Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research report on Wednesday, October 23rd. Needham & Company LLC raised their target price on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Finally, JMP Securities upped their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a report on Thursday, October 31st. Two analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $427.83.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 80,300 shares of the firm’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $371.78, for a total transaction of $29,853,934.00. Following the completion of the transaction, the chief executive officer now owns 3,015,366 shares of the company’s stock, valued at approximately $1,121,052,771.48. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other news, Director Jeri Williams sold 110 shares of the stock in a transaction on Monday, September 30th. The stock was sold at an average price of $400.00, for a total value of $44,000.00. Following the sale, the director now directly owns 1,934 shares of the company’s stock, valued at approximately $773,600. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Patrick W. Smith sold 80,300 shares of Axon Enterprise stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $371.78, for a total value of $29,853,934.00. Following the completion of the transaction, the chief executive officer now directly owns 3,015,366 shares of the company’s stock, valued at approximately $1,121,052,771.48. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 369,172 shares of company stock worth $136,270,842 over the last ninety days. 5.70% of the stock is owned by corporate insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.